A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/40 (2006.01) A61K 31/5517 (2006.01) A61P 25/22 (2006.01) C08B 37/16 (2006.01)
Patent
CA 2401424
Pharmaceutical composition for transmucosal delivery contains an inclusion complex of alprazolam and a water soluble unsubstituted or substituted beta- or gamma-cyclodextrin such as 2- hydroxypropyl beta-cyclodextrin, and a pharmaceutically acceptable carrier therefor. The pharmaceutical composition is of particular application in the treatment of Generalised Anxiety Disorder or for the management of panic disorders.
L'invention concerne une composition pharmaceutique destinée à l'administration transmucosale et qui contient un complexe d'inclusion d'alprazolame et de la beta- ou gamma - cyclodextrine substituée ou non, soluble dans l'eau, comme par exemple de la beta-cyclodextrine de 2-hydroxypropyle, et un transporteur acceptable au plan pharmaceutique prévu à cet effet. Cette composition pharmaceutique s'utilise particulièrement dans le traitement du trouble d'anxiété généralisé ou dans celui des troubles paniques.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Farmarc Nederland Bv
LandOfFree
Alprazolam inclusion complexes and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alprazolam inclusion complexes and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alprazolam inclusion complexes and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1412334